Does TECLISTAMAB-CQYV Cause Injection site reaction? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Injection site reaction have been filed in association with TECLISTAMAB-CQYV. This represents 1.1% of all adverse event reports for TECLISTAMAB-CQYV.
18
Reports of Injection site reaction with TECLISTAMAB-CQYV
1.1%
of all TECLISTAMAB-CQYV reports
0
Deaths
1
Hospitalizations
How Dangerous Is Injection site reaction From TECLISTAMAB-CQYV?
Of the 18 reports, 1 (5.6%) required hospitalization.
Is Injection site reaction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TECLISTAMAB-CQYV. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does TECLISTAMAB-CQYV Cause?
Cytokine release syndrome (406)
Immune effector cell-associated neurotoxicity syndrome (153)
Off label use (122)
Death (116)
Plasma cell myeloma (96)
Infection (83)
Neutropenia (74)
Fatigue (72)
Pyrexia (67)
Covid-19 (64)
What Other Drugs Cause Injection site reaction?
ETANERCEPT (9,962)
ADALIMUMAB (4,375)
NALTREXONE (4,360)
DUPILUMAB (4,129)
GLATIRAMER (3,317)
IXEKIZUMAB (1,701)
METHOTREXATE (1,663)
TIRZEPATIDE (1,389)
TOCILIZUMAB (1,343)
CERTOLIZUMAB PEGOL (1,253)
Which TECLISTAMAB-CQYV Alternatives Have Lower Injection site reaction Risk?
TECLISTAMAB-CQYV vs TEDIZOLID
TECLISTAMAB-CQYV vs TEDUGLUTIDE
TECLISTAMAB-CQYV vs TEDUGLUTIDE\WATER
TECLISTAMAB-CQYV vs TEGAFUR
TECLISTAMAB-CQYV vs TEGAFUR\URACIL